Mathematical analysis of the regulation of competing methyltransferases by Reed, Michael C. et al.
Reed et al. BMC Systems Biology  (2015) 9:69 
DOI 10.1186/s12918-015-0215-6
RESEARCH ARTICLE Open Access
Mathematical analysis of the regulation of
competing methyltransferases
Michael C. Reed1*, Mary V. Gamble2, Megan N. Hall2 and H. Frederik Nijhout3
Abstract
Background: Methyltransferase (MT) reactions, in which methyl groups are attached to substrates, are fundamental
to many aspects of cell biology and human physiology. The universal methyl donor for these reactions is S-adenosyl
methionine (SAM) and this presents the cell with an important regulatory problem. If the flux along one pathway is
changed then the SAM concentration will change affecting all the other MT pathways, so it is difficult for the cell to
regulate the pathways independently.
Methods: We created a mathematical model, based on the known biochemistry of the folate and methionine cycles,
to study the regulatory mechanisms that enable the cell to overcome this difficulty. Some of the primary mechanisms
are long-range allosteric interactions by which substrates in one part of the biochemical network affect the activity of
enzymes at distant locations in the network (not distant in the cell). Because of these long-range allosteric interactions,
the dynamic behavior of the network is very complicated, and somathematical modeling is a useful tool for investigating
the effects of the regulatorymechanisms and understanding the complicated underlying biochemistry and cell biology.
Results: We study the allosteric binding of 5-methyltetrahydrofolate (5mTHF) to glycine-N-methyltransferase (GNMT)
and explain why data in the literature implies that when one molecule binds, GNMT retains half its activity. Using the
model, we quantify the effects of different regulatory mechanisms and show how cell processes would be different if
the regulatory mechanisms were eliminated. In addition, we use the model to interpret and understand data from
studies in the literature. Finally, we explain why a full understanding of how competing MTs are regulated is important
for designing intervention strategies to improve human health.
Conclusions: We give strong computational evidence that once bound GNMT retains half its activity. The long-range
allosteric interactions enable the cell to regulate the MT reactions somewhat independently. The low Km values of
many MTs also play a role because the reactions then run near saturation and changes in SAM have little effect. Finally,
the inhibition of the MTs by the product S-adenosylhomocysteine also stabilizes reaction rates against changes in SAM.
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Background
Methyltransferase reactions, in which methyl groups are
attached to substrates, are fundamental to many aspects
of cell biology and human physiology. In mammals there
are at least 150 methyl transferases that methylate DNA,
RNA, lipids, proteins, and small molecules [1, 2]. For
example, the methylation of cytosines in DNA is the
basis for epigenetic control, the methylation of guani-
dinoacetate to form creatine is fundamental to energy
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metabolism, and the methylation of arsenic is an impor-
tant detoxification pathway. The universal methyl donor
in cells is the molecule S-adenosylmethionine (SAM)
that is synthesized from the amino acid methionine in
the methionine cycle. This poses an unusual but impor-
tant regulatory challenge for cells. If one methyltrans-
ferase (MT) is upregulated by the cell, then there will
be a larger flux on that pathway, which should lower
the SAM concentration and thereby decrease the flux
through the other methylation pathways. That is, it is
not clear how the cell can regulate the different methyl-
transferase pathways independently. Even 40–50 years ago
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when many methyltransferases were being discovered,
researchers understood that this is an important issue and
often referred to “competing methyltransferases” [3].
Many methyl groups used in the MT reactions come
directly from dietary input of methionine, betaine, and
choline (to make betaine) in the methionine cycle. See
Fig. 1. However, the folate cycle can also contribute
methyl groups in a process called methylneogenesis.
In the folate cycle, a methyl group is removed from
serine (making glycine) in the SHMT reaction and is
attached to tetrahydrofolate (THF) making methylene-
tetrahydrofolate (CH2-THF). See Fig. 1, and its legend for
the full names of enzymes. In turn, CH2-THF is reduced
by the enzyme MTHFR to 5-methyltetrahydrofolate
(5mTHF). In the methionine synthase (MS) reaction,
5mTHF donates the methyl group to homocysteine (Hcy)
to make methionine. As we will see, methylneogenesis is
partially controlled by the concentration of SAM itself.
Mudd and Poole [4] showed that if humans are given
diets restricted in methionine, choline, and betaine, the
subjects maintained the overall flux through theMT reac-
tions and Davis et al. [5] determined that 100 % of these
new methyl groups come from serine. Nijhout et al. [6]
showed, using mathematical modeling, that, in addition to
dietary input of serine, the mitochondria are an important
source of serine in adult cells by converting glycine to
serine.
We include five methyltransferases in our model.
GNMT, PEMT, and GAMT are included because together
they carry most of the methylation flux [7, 8]. DNMT is
included because it is an example of the many methyl-
transferases that have a very low Km for SAM and it is a
methyltransferase that is greatly up regulated when cells
divide. Finally, we include AS3MT because the detoxifica-
tion of arsenic is a special interest of ours. Given the bio-
logical importance of theMT reactions, it is not surprising
that many regulatory mechanisms have evolved that allow
the cell to regulate the methylation fluxes through the
different pathways more or less independently. These are:
(1) Long-range interactions The long-range interac-
tions are depicted by red arrows in Fig. 1. “Long-range”
does not refer to distance inside the cell (we assume that
all species are at high enough concentration that we can
consider the cell to be well-mixed). We use the term
“long-range” when a substrate affects an enzyme at a dis-
tant location in the network diagram. The concentration
of SAM affects the activity of enzymes at distant locations
in the biochemical network. SAM activates CBS [9, 10]
and inhibits BHMT [11]. As the SAM concentration rises
Fig. 1 Folate and methionine metabolism with competing methyltransferases. Substrates are indicated by rectangular boxes, green in the methionine
cycle and red in the folate cycle, except for GNMT which is both an enzyme and a substrate since it can bind to two molecules of 5mTHF. Each
arrow represents a biochemical reaction and the blue ellipse on the arrow contains the acronym of the enzyme that catalyzes the reaction. Substrate
abbreviations: Met, methionine; SAM, S-adenosylmethionine; SAH, S-adenosylhomocysteine; Hcy, homocysteine; 5mTHF, 5-methyltetrahydrofolate; THF,
tetrahydrofolate; 10fTHF, 10-formyltetrahydrofolate; DHF, dihydrofolate; CH2-THF, 5,10-methylenetrahydrofolate; CH=THF, 5,10-methenyltetrahydrofolate.
Enzyme abbreviations: AICAR(T), aminoimidazolecarboxamide ribonucleotide (transferase); FTD, 10-formyltetrahydrofolate dehydrogenase; FTS,
10-formyltetrahydrofolate synthase; MTCH, 5,10-methylenetetrahydrofolate cyclohydrolase; MTD, 5,10-methylenetetrahydrofolate dehydrogenase;
MTHFR, 5,10-methylenetetrahydrofolate reductase; TS, thymidylate synthase; SHMT, serine hydroxymethyltransferase; PGT, phosphoribosyl
glycinamidetransformalase; DHFR, dihydrofolate reductase; NE, nonenzymatic interconversion of THF and 5,10-CH2-THF; MAT-I,methionine adenosyl
transferase I; MAT-III, methionine adenosyl transferase III; GNMT, glycine N-methyltransferase; AS3MT, arsenic methyltransferase; PEMT,
phosphotidylethanolamine methyltransferase; GAMT, gunadino-acetate methyltransferase; DNMT, DNA-methyltransferase; SAHH, S-adenosylhomocy
steine hydrolase; CBS, cystathionine β-synthase; MS, methionine synthase; BHMT, betaine-homocysteine methyltransferase
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this has the effect of sending more Hcy down the transsul-
furation pathway (CBS) and remethylating fewer Hcy
(BHMT) to methionine, thus moderating the increase
in SAM. In a series of papers, Finkelstein and Martin
[12, 13] emphasized that these effects tend to conserve
the total mass in the methionine cycle. In addition, SAM
inhibits the enzyme MTHFR [14]. Thus when the SAM
concentration increases, the concentration of 5mTHF will
drop and the MS reaction will go slower, so less Hcy will
be remethylated to methionine.
(2) The binding of 5mTHF to GNMT Zamierowski and
Wagner [15] discovered that the GNMT is a major folate
binding protein. 5mTHF binds to GNMT and tends
to inactivate it; see Fig. 1. Thus, when SAM starts to
rise, the inhibition of MTHFR causes the concentra-
tion of free 5mTHF to fall causing some of the bound
GNMT-5mTHF complexes to dissociate. This makes
more free GNMT so the GNMT pathway runs faster
preventing the SAM concentration from rising too much.
Conversely, if SAM starts to fall, the inhibition of MTHFR
is partially relieved creating more 5mTHF. The increased
5mTHF binds to more GNMT, lowering the amount
of free GNMT available for the GNMT reaction, thus
moderating the decline in SAM concentration. Because
of these ideas, Wagner and others refer to the GNMT
reaction as a “salvage pathway”. When SAM is high
many of the excess methyl groups are carried away in
the GNMT reaction and when SAM is low the GNMT
reaction is constricted to save the methyl groups for the
other MT reactions. This view is consistent with the fact
that the product of the GNMT reaction, sarcosine, has no
known physiological function. It is transported into the
mitochondria where the one carbon units are stripped off
and (except for one CO2) returned to the folate cycle in
the cytosol.
(3) SAH inhibits the MT reactions Almost all the MT
enzymes are inhibited by S-adenosylhomocysteine
(SAH), the universal product of the MT reactions. This
also tends to maintain the SAM concentration. If one
MT is highly upregulated, the increased flux will raise
the concentration of SAH, which will inhibit somewhat
more the other MT reactions, thus tending to maintain
the concentration of SAM.
(4) Many MT have very low Km values for SAM Some
MT enzymes have Km values for SAM that are of the
same magnitude as typical SAM concentrations. This
includes GNMT, GAMT, and PEMT, three pathways that
carry a major amount of the MT flux. However, many
other MT enzymes, for example DNMT, have very low
Km values for SAM [1]. This ensures that even if the SAM
concentration fluctuates the velocity of the particular MT
reaction won’t change much because it is already on the
saturated part of the Michaelis-Menten curve.
The main purpose of this study is to investigate, using
mathematical modeling, these regulatory mechanisms.
The first step is to use information about the binding
of 5mTHF to GNMT recently discovered by Luka and
Wagner [16–18] so that we can update and improve our
previous models of folate and methionine metabolism in
the liver [6, 19, 20]. We present, in Section The binding
of 5mTHF to GNMT, evidence from the mathematical
modeling that GNMT retains 50 % of its activity when
it is once bound by 5mTHF but not when it is twice
bound. Then we study the five competing methyltrans-
ferases indicated in Fig. 1: GNMT, the salvage pathway,
PEMT and GAMT, major MT pathways with moder-
ate Km values for SAM, DNMT, which has a low Km
value for SAM, and AS3MT, the enzyme in the arsenic
detoxification pathway that is a particular interest of
ours. In Section Stabilization of methylation reactions by
the long-range interactions we show that the long-range
interactions moderate the effects on other fluxes when
one flux is eliminated or highly upregulated. In Section
Stabilization of SAM against changes in methionine
input we show how the long-range interactions moder-
ate the effects of changes in methionine input. And, in
Section Methylation and folate deficiency we show that
even though the SAM concentration depends on total
liver folate, the total methylation flux is not markedly
affected by folate deficiency. In Section The importance
of small Km values we explain the importance of the
small Km values for SAM of many MTs and in Section
The effect of inhibition by SAH we study the inhibition of
the MT reactions by SAH. In Section The importance of
substrate availability we point out that individual methy-
lation fluxes can be controlled by co-substrate availability
as well as enzyme expression level. In Section Arsenic
in Bangladesh, we explain why a full understanding of
how competing MTs are regulated is important for under-
standing and designing intervention strategies for human
health effects. We also explain that there are times when
one would like to break some or all of these homeo-
static mechanisms so as to achieve specific changes in
the balance of the MT pathways. In addition, we use the
model to interpret and understand data from studies in
the literature.
Methods
A schematic diagram of the mathematical model is shown
in Fig. 1. The pink boxes indicate the variable substrates in
the folate cycle and the green boxes indicate the variable
substrates in the methionine cycle. Each arrow repre-
sents a biochemical reaction and the blue ellipses on the
arrows give the acronyms of the enzymes catalyzing the
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reactions. Full names of substrates and enzymes are given
in the legend to Fig. 1. In addition, the concentration of
the free enzyme, GNMT, is treated as a variable in the
model, as well as its singly bound and doubly bound forms,
5mTHF-GNMTand 5mTHF-GNMT-5mTHF, respectively.
The concentration of each variable satisfies a differential
equation that represents mass-balance; that is, the rate of
change of the variable (in μM/hr) is simply the sum of the
rates of the arrows coming into the variableminus the sum
of the rates of the arrows leaving the variable. Thus, the
differential equation for [SAM] is
d[SAM]
dt
= VMATI([Met] , [ SAM]) + VMATIII([Met] , [SAM])
− VGNMT([SAM] , [SAH] , [GNMT] , [5mTHF-GNMT])
− VAS3MT([SAM] , [SAH]) − VPEMT([SAM] , [SAH])
− VGAMT([SAM] , [SAH]) − VDNMT([SAM] , [SAH])
Each V is a velocity and the subscript indicates which
reaction. Each velocity depends on the current value of
the concentrations of the indicated variables. The com-
plicated, usually non-linear, form of this dependence
depends on the detailed biochemistry of each of the
enzymes. Each of the methylation reactions also depends
on the concentration of the substrate being methylated,
for example glycine for GNMT and guanadino-acetate
for GAMT, though we do not indicate these explicitly.
These methylation substrates are taken to be constant in
the model because our main interest is the regulation of
[SAM] concentration.
The complete mathematical model that consists of 13
differential equations and explicit formulas for each reac-
tion velocity is given in the Additional file 1. Large parts
of the model are very similar to the liver folate and
methione cycle parts of (larger) models that we have
developed in the past to study different aspects of cell
metabolism. The contributions of the mitochondria to
one-carbon metabolism were studied in [6]. The tran-
sulfuration pathway was studied in [21] and whole body
folate and methione metabolism was studied in [22]. In
the rest of this section we present the new reactions and
substrates that we have added in order to study the prob-
lem of competing methyltransferases. Full details of the
complete model are available in the Additional file 1.
Binding of 5mTHF to GNMT
In a series of papers, Wagner, Luka, and colleagues have
studied the inhibitory effect of 5mTHF on the activity of
GNMT [17, 18, 23–25]. GNMT has two binding sites for
5mTHF, so we assume the simple reversible reactions:
5mTHF + GNMT  5mTHF-GNMT
5mTHF-GNMT + 5mTHF  5mTHF-GNMT-5mTHF
with forward and backward rate constants, k1 and
k2, for the first reaction and k3 and k4, for the sec-
ond reaction. Thus the differential equations for




= VMTHFR([CH2-THF] , [SAM])















= + k3[5mTHF-GNMT][ 5mTHF]
− k4[5mTHF-GNMT-5mTHF]
We choose the rate constants k1 = 50, k2 = 1, k3 = 1,
k4 = 1.6 so that the KD values are those found in Table
two of [17].
GNMT
The kinetics of GNMT for SAM are cooperative and we
take the Hill coefficient to be n = 2 as suggested in [24]
and we use Km = 100 μM as indicated in [1]. The inhibi-
tion by SAH is competitive [26] and has Ki = 35 μM [1].
Of course, the reaction has glycine as a substrate but we
take the glycine concentration to be constant so it’s effect
is included in Vmax = 4000 μ/hr. Thus,










Vmax = (4000)([GNMT] + (.5)[5mTHF-GNMT]).
This formula for Vmax resulted from our in silico
experiments described in the first section of Results.
The concentration of free GNMT, [GNMT], is a vari-
able in our model. GNMT can be bound by one or two
molecules of 5mTHF. Our simulations and the data in
[17] suggest strongly that once bound GNMT, namely
[5mTHF-GNMT], retains 50 % of it’s activity. The factor
4000 is chosen so that the GNMT has a normal reaction
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velocity comparable to the reaction velocities of PEMT
and GAMT, the two other methyl transferases that carry
much of the methylation flux.
AS3MT
Inorganic arsenic is metabolized in two methylation steps
catalyzed by AS3MT. The first step uses utilizes a methyl
group from SAM and is followed by a reduction step to
producemethylarsonic acid (MMA). The second step uses
utilizes a methyl group from SAM and is followed by a
reduction step to produce dimethyarsinic acid (DMA),
which is readily exported from the liver and cleared in the
urine. We have recently studied the biochemistry of these
methylation steps that are quite complicated [27]. For,
example the first step shows substrate inhibition by inor-
ganic arsenic and product inhibition by MMA and glu-
tathione (GSH) both sequesters the arsenic compounds
and activates AS3MT. In our study here, we are mainly
interested in studying the availability of methyl groups
from SAM, so we take the arsenic concentrations and the
GSH concentration to be constant, and model just the
first methylation step. SAM shows substrate inhibition for
AS3MT [24], but the effect is small and occurs only at
very high SAM concentrations, so we ignore it. Thus, the
velocity of methylation is taken to be:







We take the Km of AS3MT for SAM to be 50 μM as
determined in [28]. It is known that SAH inhibits AS3MT
[29, 30], but the nature of the inhibition and the Ki are
not known. We’ll assume the inhibition is competitive
and take Ki = 10 μM, which is typical of other methyl-
transferases. A high, but realistic arsenic load is 1 μM in
liver [31] and a typical flux would be the order of mag-
nitude of 1 μM/hr. So, we choose Vmax = 5 μ/hr, which
accomplishes this given that a typical SAM concentration
is 24 μM.
PEMT
The velocity of the PEMT reaction is given by





The inhibition by SAH is non-competitive [32]. We
choose Km = 18.2 μM for SAM and Ki = 3.8 μM for
SAH as indicated in [1]. The reaction depends on phos-
phatidylethanolamine but since we take its concentration
to be constant we fold that dependence into the Vmax.
The value Vmax = 250 μM/hr was chosen so that the
flux of the PEMT reaction is comparable to the fluxes of
the GNMT and GAMT reactions, the two other methyl
transferases that carry much of the methylation flux.
GAMT
The velocity of the GAMT reaction is given by








The inhibition by SAH is competitive [33, 34]. We
choose Km = 49 μM for SAM and Ki = 16 μM for SAH
as indicated in [1]. The reaction depends on the effective
concentration of the cytosine substrates, but since we take
its concentration to be constant we fold that dependence
into the Vmax. The value Vmax = 100 μM/hr was chosen
so that the flux of the GAMT reaction is comparable to the
fluxes of the GNMT and PEMT reactions, the two other
methyl transferases that carry much of the methylation
flux.
DNMT
The velocity of the DNMT reaction is given by







The inhibition by SAH is competitive [35]. We choose
Km = 1.4 μM for SAM and Ki = 1.4 μM for SAH as
indicated in [36]. The reaction depends on guanidinoac-
etate but since we take its concentration to be constant
we fold that dependence into the Vmax. The value Vmax =
12.5 μM/hr was chosen so that the flux of the DNMT
reaction is normally (when the cell is not dividing) much
less than the fluxes of GNMT, PEMT, and GAMT.
The fluxes of each of the MT reactions depends
on the availability of co-substrates, for example phos-
phatidylethanolamine for the PEMT reaction or guanidi-
noacetate (gaa) for the GAMT reaction. We take these
co-substrates to be constant in our simulations, so, for
simplicity, the co-substrate terms are not shown in the
above formulas. Full formulas with the co-substrates in
the cases of AS3MT, GNMT, GAMT, and PEMT are given
in the Additional file 1. The Vmax values given here and
in the Additional file 1 differ somewhat because of the
presence of these extra terms.
On the use of Michaelis-Menten kinetics
Almost all of our formulas for reactions velocities have
Michaelis-Menten form, for example V = Vmax[S] /
(Km + [S]), modified to include the effects of product inhi-
bition, substrate inhibition, or long-range allosteric inter-
actions. All of the explicit formulas are in the Additional
file 1. These formulas are simplifications of underlying
biochemical processes that are more complicated. For
example, the actual sequence of steps of the MS reaction,
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worked out by Rowena Matthews and others, is very long
and complicated (and involves SAM). But we are mainly
interested in how overall reaction velocity depends on the
concentrations of Hcy and 5mTHF, so we use the simple
bi-molecular Michaelis-Menten formula until we think
that the details of the mechanism are important for the
questions we are trying to answer. Deciding what level of
biological and biochemical detail to include is always a
difficult and important issue. We use simple formulations
until the data that we are trying to understand suggests to
us that the details on a lower level may be relevant.
Results and discussion
The binding of 5mTHF to GNMT
It was established as early as 1985 by Wagner and co-
workers [23] that 5mTHF inhibits the enzyme GNMT;
15 % inhibition was shown at 0.1 μMof 5mTHF pentaglu-
tamate, 50 % inhibition at 1 μM and 90 % inhibition at
10 μM. Since then, Wagner, Luka, and co-workers have
investigated the structure of GNMT and the binding of
5mTHF. In [24] it was shown that the binding of SAM to
GNMT is cooperative and depends on the 5mTHF con-
centration and GNMT and shows substrate inhibition for
SAM at high SAM concentrations. In [16, 37] the struc-
ture of GNMT was elucidated and it was shown that
GNMT can bind two molecules of 5mTHF. In [17], KD
values for the binding of 5mTHF to GNMT are given and
inhibition curves and free versus bound 5mTHF curves
are given.
Left open was the question of what the activity
of the enzyme GNMT is when it is once bound or
twice bound with 5mTHF. To investigate this ques-
tion we used the four differential equations given in
Methods for [5mTHF] , [GNMT] , [5mTHF-GNMT] and
[5mTHF-GNMT-5mTHF]. GNMT is 1–3 % of liver pro-
tein [26] and in [37] the GNMT concentration in liver was
measured to be 1 μM, so we assume that GNMT con-
centration in our in silico experiments and take the KD
values from [17]. Our results are shown in Fig. 2. Panel a
shows the concentrations of [GNMT] , [5mTHF-GNMT]
and [5mTHF-GNMT-5mTHF] as a function of the total
concentration of [5mTHF] in the medium. Panel b shows
our computed model curve of bound 5mTHF versus free
5mTHF along with the data points from Figure 2 of [17].
The match of the computed curve to the data is very good.
Note that since there is 1 μM of GNMT in the mixture
and the curve and the data rise to 1.7 μM, this shows
conclusively that two molecules of 5mTHF can bind to
each GNMT. Finally, in Panel c we show the data points
from the inhibition curve given in Figure 3 of [17] and
two different model curves. The red curve shows the
% activity of GNMT assuming that free GNMT has 100 %
activity and once bound and twice bound GNMT have 0 %




Fig. 2 Binding of 5mTHF to GNMT. Panel a shows the concentrations
of the three substrates, free GNMT (blue curve), GNMT -5mTHF(red),
and 5mTHF-GNMT -5mTHF(green) as a function of the concentration
of 5mTHF. Total GNMT concentration is 1 μM. Panel b shows the
concentration of bound 5mTHF as a function of total 5mTHF. The
open circles are data replotted from [17], Fig. 2, and the blue curve is
the model calculation. The concentration of GNMT is 1 μM. Since the
concentration of bound 5mTHF goes well above 1 μM, this proves
conclusively that two 5mTHF can bind to each GNMT . The data (open
circles) in Panel c, taken from [17], Fig. 3, shows how the activity of
GNMT decreases from 1 (normal) as the concentration of 5mTHF
increases. The red curve shows the activity of GNMT, as computed by
the model, if one assumes that once and twice bound GNMT lose all
activity. The green curve shows the activity of GNMT as computed by
the model if one assumes that once and GNMT has 50 % activity and
twice bound GNMT has no activity. The green curve gives an excellent
fit to the data
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hand, the green curve shows the computed % activity of
GNMT assuming that free GNMThas 100 % activity, once
bound GNMT has 50 % activity, and twice bound GNMT
has 0 % activity. The computed curve lies very close to
the data points. We conclude from these computational
experiments that it is very likely that once bound GNMT
retains 50 % of its activity.
Stabilization of methylation reactions by the long-range
interactions
We performed various computational experiments that
show the effects of the long-range interactions. Since our
results are presented as percentage change from normal,
we begin by briefly discussing the normal steady state con-
centrations and velocities in the model that are indicated
in Table 1. Our mathematical model, shown schematically
in Fig. 1, differs from previous models [19, 20, 22] in three
ways: (1) We have added the PEMT, GAMT, and AS3MT
methylation reactions; (2) We treat the binding of 5mTHF
to GNMT in much more detail; (3) We have lowered the
methionine input to the liver to 50 μM/hr so that the
steady state concentration of SAM (23.97) is in the range
indicated for humans in [38, 39]. The methionine concen-
tration is correspondingly low. Total folate concentration
in the liver is 20 μM [19] and the 5mTHF concentration is
5.35 μM [19]. The fraction of the flux around the methio-
nine cycle that enters the transsulfuration pathway (“frac”)
is 0.5 [12].
The flux around the methionine cycle, 100.25 μM/hr, is
given by the net flux of the reaction from SAH to Hcy.
The three major methylation fluxes are those catalyzed by
GNMT, PEMT, and GAMT [7, 8] and they carry most of
the normal flux in our model. The fluxes through DNMT
and AS3MT are small representing two of the many other
methyltransferases. The remethylation flux from Hcy to
Met in the liver is almost equally divided betweenMS and
BHMT and the CBS flux at steady state must be 50μM/hr
since that is the methionine input.
Table 1 Normal values of concentrations (μM) and velocities
(μM/hr)
Concentrations Velocities
Met 17.97 metin 50
SAM 23.97 VAH 100.25
SAH 3.89 VGNMT 43.97
Hcy 2.27 VDNMT 2.05
5mTHF 5.35 VGAMT 25.42
Folate total 20 VPEMT 27.53
Frac .50 VASMT 1.28
VMS 23.65
VBHMT 26.60
Our first computational experiments investigate how
sudden drastic changes in the amounts of PEMT, GAMT,
GNMT, or DNMT affect the other fluxes. In Panel a of
Fig. 3, we show the percentage change of each of the other
fluxes if one flux is set to zero or if the amount of DNMT is
multiplied by a factor of 20. Note that a flux could become
zero if either the enzyme expression level goes to zero
or the co-substrate concentration is zero. Across the bot-
tom we indicate which of the fluxes has been altered. As
expected, if one enzyme is set to zero the other fluxes go
up and if DNMT is upregulated by a factor of 20, the other
fluxes go down. The percentage changes when PEMT or
GAMT is set to zero (appoximately 20 %) are consistent
with the PEMT and GAMT knockout changes discussed
in [7]. The most dramatic changes come when GNMT is
knocked out, which was also seen in [7]. When DNMT is
upregulated by a factor of 20, the three fluxes of GNMT,
PEMT, and GAMT decrease modestly. One can clearly
see the influence of GNMT as the “salvage” pathway first
described by Wagner, Briggs, and Cook [23]. If PEMT is
knocked out GNMT flux goes up a lot so that the GAMT
flux does not rise very much. Similarly, when DNMT is
upregulated, the GNMT flux drops dramatically and so
PEMT and GAMT do not drop as much.
Panel b of Fig. 3 shows what happens if we do the same
experiments but turn off the long-range interactions. In
every case the changes to the fluxes are larger when one
flux is knocked out or (in the case of DNMT) upregulated.
Some differences are quite large. If GNMT is knocked out,
then GAMT increases by 55 % in the presence of the long-
range interactions and increases by 121 % with no long-
range interactions.
By examining Fig. 1 and Panel a of Fig. 4, we can see how
these long-range interactions work. Consider the case
where PEMT is knocked out. SAM goes up 25 % inhibit-
ingMTHFRmore and thus lowering 5mTHF by 14 %. This
drives the reaction of 5mTHF with GNMT towards dis-
sociation so there is less double bound GNMT and more
single bound GNMT (by about 10 %), which increases
the flux in the GNMT reaction. This is why (see Fig. 3,
Panel a) the GNMT flux goes up a lot, but the GAMT
flux goes up less (about 20 %) and DNMT flux goes up
very little. Finally, the fraction of flux transsulfurated goes
up, because increased SAM stimulates CBS and inhibits
BHMT, and this moderates the increase in SAM. The
analogous scenario happens when GAMT is knocked out.
The opposite scenario happens if DNMT is upregulated
by a factor of 20. The steady state value of SAM goes
down by 22 %, which removes inhibition from MTHFR,
so 5mTHF goes up by 18 %. This drives the reaction of
5mTHF with GNMT towards binding and so the amount
of once bound GNMT goes down. Thus less flux goes
through the GNMT reaction allowing the the PEMT
and GAMT reactions to decrease more modestly (Fig. 3,
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a b
Fig. 3 Steady state changes in methylation velocities when one velocity is knocked out or upregulated. Panel a shows the percentage changes in
methylation velocities in the model when either PEMT, GAMT, or GNMT is knocked out, or when DNMT is 20-fold upregulated. Because of the
long-range interactions, GNMT flux changes a lot so that the change is SAM is modest and the PEMT and GAMT fluxes do not change so much.
Panel b shows the results of the same experiments in the case that the long-range interactions are turned off. All the changes are greater than those
in Panel a
Panel a). Finally, since SAM goes down, the fraction tran-
sulfurated decreases by 10 %, which recycles more methyl
groups back to methionine for the transmethylation
reactions.
This beautiful mechanism is broken if GNMT is
knocked out. As one can see in Panel a of Fig. 4, SAM
increases dramatically and this causes very large increases
in the fluxes through PEMT, GAMT, and DNMT (Panel
a of Fig. 3). And if there are no long-range interactions
at all (Panel b of Fig. 4), SAM goes way up or way down
without changing GNMT-5mTHF, 5mTHF, or the fraction
transsulfuratedmuch. The large changes in SAMdrive the
increased changes in the fluxes seen in Panel b of Fig. 3.
Stabilization of SAM against changes in methionine input
Since SAM is the universal methyl group donor, its con-
centration determines the availability of methyl groups
for the transmethylation reactions. This presents a prob-
lem for the cell since the precursor of SAM is methionine
and the methionine concentration in the blood varies
dramatically during the day due to meals. We have previ-
ously carried out a fluctuation analysis that showed how
the long-range interactions greatly dampen the fluctu-
ations in methionine input and cause the flux through
the DNMT reaction to remain quite stable [20]. Here
we show how the steady state value of SAM depends
on methionine input (Fig. 5). With the long-range inter-
actions present (green curve) the steady state value of
SAM increases fairly slowly and linearly as methionine
input increases from 10 μM/hr to 100 μM/hr. When
the long-range interactions are removed (red curve), the
steady state value of SAM increases much more rapidly
and accelerates as the methionine input increases. In both
cases the SAM concentration increases dramatically at
a b
Fig. 4 Steady state changes in substrate concentration and fraction transsulfurated when one velocity is knocked out or upregulated. Panel a shows
the percentage changes in SAM, GNMT-5mTHF, and 5mTHF concentrations, and fraction transsulfurated in the model when either PEMT, GAMT, or
GNMT is knocked out, or when DNMT is 20-fold upregulated. The long-range interactions cause substantial changes in all four variables and these
changes are what make the velocity changes in Panel a of Fig. 3 relatively modest. Panel b shows what happens when the long-range interactions
are turned off. The GNMT-5mTHF, 5mTHF concentrations, and fraction transsulfurated don’t change at all (except in the case of GNMT knockout),
but SAM undergoes enormous changes
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Fig. 5 Dependence of SAM on methionine input. When the long-range
interactions are present (green curve), the steady state value of SAM
increases slowly and linearly as methionine input is increased over a
wide range. When the long-range interactions are removed (red
curve), the steady state value of SAM increases more rapidly and
accelerates when methionine input becomes high. Both curves show
the “substrate switch” [41] in which the steady state value of SAM
rises modestly at first as methionine input rises but after a certain
point rises extremely rapidly
high values of methionine input. This is the behavior
seen in the models of [40, 41] where they call it a “sub-
strate switch,” and the in vitro experiments [41]. Figure 5
shows that the switch occurs much earlier without the
long-range interactions. These results are consistent with
the classic experiments of Finkelstein and Martin who
fed rats diets with different amounts of methionine and
measured liver SAM (Table 1 in [42]). As the methion-
ine content of their diets increased, rats showed relatively
modest increases in the SAM concentrations in their liv-
ers until at very high methionine diets SAM increased
dramatically. All homeostatic mechanisms, including the
long-range interactions discussed here, can be broken if
inputs become too extreme, a phenomenon that is dis-
cussed further in [43].
Methylation and folate deficiency
There is a positive statistical association between
liver folate status and liver SAM concentration [44].
Using a mathematical model of folate and methionine
metabolism, we showed that over normal physiological
ranges liver SAM concentration is a linear increasing
function of total liver folate [45] and later more detailed
models show the same behavior [21]. Figure 6, Panel a,
shows that this is true both in the presence of and without
the long-range inhibitions. The reason is easy to under-
stand. Higher total folate means higher 5mTHF, which
drives the MS reaction faster and remethylates more Hcy
to become Met. Much more interesting is the depen-
dence of total methylation rate (i.e., the sum of all five
fluxes in the model) on folate status as shown in Panel
b of Fig. 6. In the presence of the long-range interac-
tions, there is almost no decrease in total methylation
flux (despite the decrease in SAM) as folate deficiency
becomes more andmore severe (green curve). In contrast,
total methylation flux goes down rapidly as folate defi-
ciency increases if the long-range interactions are absent
(red curve). Thus, one evolutionary purpose of the long-
range interactions may have been to protect the methy-
lation reactions against the folate deficiencies that surely
developed during Fall and Winter when green vegetables
were scarce.
For all of our model simulations it is natural to ask how
sensitive the results are to the exact choices of parame-
ters. The answer is not much. There are 11 Vmax values
for the velocities around the methionine cycle. We con-
ducted experiments in which each these Vmax values was
modified by multiplying it by a number chosen randomly
between 0.9 and 1.1 (maximal 10 % variation). All the
Vmax values were changed simultaneously and indepen-
dently. The green and red shaded areas in Fig. 6b are
the envelopes of the values we obtained in 10 such sim-
ulations. As one can see, the fundamental conclusion of
Fig. 6b remains the same, whichever set of Vmax values
one has chosen: the long-range interactions stabilize total
methylation rate against folate deficiency. The individual
variation of enzyme parameters likeVmax andKm values is
not known. We chose 10 % not to represent real biological
variation, but simply to show that the model results and
conclusions do not depend sensitively on the exact choices
of parameters.
The importance of small Km values
A notable feature of the simulations shown in Fig. 3 is that
the knockouts of PEMT, GAMT, and GNMT induce only
very small changes in DNMT. The reason is easy to under-
stand. The Km of DNMT is very small, 1.4 μM [36], com-
pared to the normal concentration of SAM, 23.94 μM, in
themodel. This means that moderate changes in SAMwill
hardly affect the velocity of the DNMT reaction, because
the velocity curve is very flat for values of SAM consider-
ably higher than the Km. One can see this effect clearly in
Fig. 7, which shows hourly changes in methionine input
(Panel e) due to three daily meals. GNMT (Panel c) and
GAMT (Panel d) show large variations due to meals but
DNMT (Panel d) shows almost no variation. This is a
very simple regulatory mechanism, but it is very com-
mon. Of the 23 Km values for methyltransferases listed
in [1], 12 have Km values ≤ 3, and 4 have Km values in
the range 3–10 μM. If a methyltransferase has a low Km
value, the cell can regulate its flux simply by changing the
expression level of the enzyme, independent of the fluxes
of the other methyltransferases or the concentration
of SAM.
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a
b
Fig. 6 The effect of folate deficiency on total methylation. The curves in Panel a show that the SAM level is a linear function of total folate level in the
liver whether the long-range interactions are present or not. This is consistent with previous studies (see text). Panel b shows that the total
methylation rate (green curve) is remarkably stable as the level of total folate decreases, despite the drop in SAM, if the long-range interactions are
present. If the long-range interactions are absent (red curve), the rate of total methylation decreases rapidly as total liver folate decreases. In order to
show dependence on parameters, we conducted the following in silico experiments. In each experiment we multiplied the Vmax of each of the 11
Vmax values in the methionine cycle by a number drawn randomly and independently from the interval [0.9,1.1]. We then generated the green and
red curves corresponding to those parameters. The shaded green and red areas show the envelopes of those curves. Although the curves depend on
the choices of parameters, the main conclusion remains the same: the long-range interactions protect total methylation flux against folate deficiency
The effect of inhibition by SAH
Most methyltransferases are inhibited by SAH, the
other product of the MT reaction. Of course, product
inhibition is ubiquitous in cell metabolism and this simple
mechanism is rightly regarded as a way of preventing
the over-accumulation of product. However, the graph
of PEMT (Panel d) in Fig. 7 suggests a different role for
inhibition by SAH. Notice that GNMT and GAMT fluc-
tuate up and down considerably with methionine input,
while PEMT does not. All three MTs have high Km
values so the discussion in Section The importance of
small Km values is not relevant. The reason that PEMT
fluctuates little is the inhibition by SAH. As indicated
by Panels a and b, the SAH concentration fluctuates up
and down with the SAM concentration. For PEMT, the
increase in SAM (which will increase flux) is almost
exactly compensated by the increase in SAH (which will
decrease flux). But why doesn’t this happen for GAMT?
The reason is that the Ki of PEMT for SAH is quite
small (3.8 μM) so the inhibition by SAH is quite pow-
erful, while the Ki of GAMT for SAH is quite large
(16 μM) so the inhibition by SAH is quite weak. Thus,
evolution may have tuned the Km and the Ki values of
certain methyltransferases for which it was important to
buffer the flux against changes in methionine input due to
meals.






Fig. 7 The effect of meals on competing methyltransferases. The input of methionine into the liver Panel e was varied during a 24 hour period:
33.33 μM/hr until breakfast, then 66.67 μM/hr for 3 hours, similarly for lunch, and for 3 hours after dinner the input is 100 μM/hr. Panel a shows the
large deviations in SAM due to themethionine input changes. Panel b shows that SAH and Hcy track the changes in SAM, but 5mTHF has the opposite
changes because SAM inhibits MTHFR (see Fig. 1). The changes in Hcy are small because SAM stimulates CBS. Panel c shows the time course of the
fluxes through GNMT, PEMT, and GAMT. As explained in the text, GNMT goes up rapidly as SAM increases taking most of the extra methyl groups so
that the changes to GAMT and PEMT are modest. The changes to PEMT are exceptionally small (see the text for Section The effect of inhibition by
SAH). Panel d shows the fluxes through AS3MT and DNMT. The changes to DNMT are exceptionally small (see the text for Section The importance of
small Km values) because the Km of DNMT for SAM is very small. By contrast, AS3MT has a much higher Km and therefore varies much more
The importance of substrate availability
In this paper we have been studying the competi-
tion between different methyltransferase reactions for
the methyl groups provided by SAM. Each of the
methyltransferase reactions has a co-substrate to which
the methyl group is given, for example phospho-
tidylethanolamine for the PEMT reaction or guanadinoac-
etate (gaa) for the GAMT reaction. In our simulations
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in Section Stabilization of methylation reactions by the
long-range interactions we looked at the effects of setting
one of the methylation fluxes to zero. This could happen
in two ways. The expression level of the enzyme could
go to zero or the concentration of the co-substrate could
become zero. In general, each methylation flux can be
regulated by adjusting expression level and/or substrate
level. Physiological systems typically have many layers of
control mechanisms and the long-range interactions dis-
cussed here are just one set of such control mechanisms in
liver metabolism. Each particular methyltransferase reac-
tion will be regulated by other mechanisms also, some of
which occur in other organs. This is nicely illustrated by
the GAMT reaction.
Creatine is produced by a two step process. In the
first step the enzyme L-arginine:glycine amidinotrans-
ferase (AGAT) makes gaa in the kidney from arginine and
glycine. gaa is exported into the plasma and is taken up
by the liver where it receives a methyl group from SAM
and becomes creatine via the GAMT reaction. The crea-
tine is exported from the liver and is taken up by muscle
tissue. Normally mammals ingest about 50 % of the crea-
tine they need and synthesize the other half through these
reactions [46, 47]. Thus, one would expect that creatine
synthesis in the liver would be sensitive to the amount of
creatine in the diet, and indeed it is [46, 47]. High plasma
concentrations in the plasma inhibit AGAT in the kidney
so that less gaa is sent to the liver and thus less crea-
tine is produced by the GAMT reaction. The second set
of bar graphs in Fig. 3a shows that if gaa is set to zero
(for example, after a high creatine meal) and therefore the
GAMT flux becomes zero, then the other MT reactions
change modestly, except for GNMT that changes a lot.
See the discussion in Section Stabilization of methylation
reactions by the long-range interactions.
Arsenic in Bangladesh
In this section we discuss why a full understanding of
the regulation of competing methyltransferases is impor-
tant for human health effects and interventions. Arsenic
in drinking water is a major health hazard to millions
of people in South and East Asia and in other parts of
the world [48, 49]. Long term arsenic exposure has been
linked to cancer, heart disease, neuropathies and neuro-
logical sequelae, and to deficits in intelligence in children
[50, 51]. Arsenic in water is normally ingested primarily
as trivalent inorganic arsenic (iAs), which then undergoes
hepatic methylation to methylarsonic acid (MMAs) and
a second methylation to dimethylarsinic acid (DMAs) by
the enzyme AS3MT.
This is considered a detoxification pathway because
DMAs is rapidly exported from the liver to the blood and
excreted in urine. Two of us (MVG and MNH) conduct
studies whose purpose is to determine which nutritional
supplements would increase the rate of the AS3MT reac-
tion and thus lower the arsenic body burden in individuals
in Bangladesh. It is known both from experimentation
[52] and frommodeling (Panel a of Fig. 6) that an increase
in folate status increases the concentration of SAM in hep-
atic cells. Thus one might predict that increasing folate
status would increase the rate of methylation of iAs;
results from a randomized clinical trial of folate supple-
mentation to folate-deficient adults in Bangladesh show
this to be true [53, 54]. Because iAs and its methylated
metabolites, MMAs and DMAs, are not measured in the
livers of human subjects but in blood and in urine, it is
important to have a whole body mathematical model that
connects arsenic metabolism in the liver to the blood and
urine concentrations of iAs, MMAs, and DMAs. We cre-
ated such a model in [31]. The model predictions matched
the observation in the Bangladesh trials that folate sup-
plementation of folate-deficient individuals reduced blood
arsenic by 14 %. With the model, we were also able to
predict that body stores of arsenic (which couldn’t be
measured) would be reduced by roughly 26 %.
This led naturally to the question of whether sup-
plementation with other nutrients, besides folate, would
improve these results. The goal is to raise SAM concen-
trations and thus to increase the availability of methyl
groups for AS3MT. A natural candidate is creatine supple-
mentation, which has been shown to downregulate cre-
atine biosynthesis through repression of arginine:glycine
amidinotransferase (AGAT) in the kidney, which, in turn,
lowers the concentration of guanidinoacetate (GAA), the
substrate for GAMT in the liver [50, 51]. And this brings
us immediately to the topic of the investigation in this
paper, the competition between methyltransferases. If
GAMT flux goes down, how much will SAM go up and
how much will that increase the flux through AS3MT?
We recently conducted some (unpublished) experiments
with our mathematical models that suggested that crea-
tine supplementation (in addition to folate supplementa-
tion) would lower blood arsenic an additional 8.5 %. The
results in this paper help us to understand why the pre-
dicted change was modest. The long-range interactions
buffer the flux through other methyltransferases when
one methyl-transferase is downregulated. In a recent con-
trolled trial in Bangladesh, 622 participants were ran-
domized to receive 400 μg folic acid, 800 μg folic acid,
3 g creatine, 3 g creatine + 400 μg folic acid, or placebo
daily [55]. The 622 participants were comprised of both
folate sufficient and deficient individuals. All participants
received a water filter that removed arsenic at the start
of the study. The results show that 800 μg folic acid
was the only treatment to lower total blood arsenic to
a significantly greater extent than placebo. However, 3 g
creatine+400 μg folic acid did lower blood arsenic to a
greater extent (14 %) than 400 μg folic acid alone (3.7 %)
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although this finding did not reach statistical significance
(p = 0.08) [55]. Furthermore, 3 g creatine + 400 μg
folic acid led to decreases in GAA that were correlated
with decreases in homocysteine (manuscript in prepara-
tion). Treatment effects on As methylation patterns are
presently being analyzed. In general, these findings are
consistent with the model predictions. Thus, to improve
the outcomes, one needs to break one or more of the
regulatory mechanisms. A possible way to do this is to
give very high levels of folate supplementation along with
the creatine supplementation. If one can raise liver folate
appreciably, one could shut down the GNMT pathway
because of the binding of 5mTHF to GNMT, and then
creatine supplementation should have a larger effect. The
difficulty is that it is easy to raise plasma folate a lot but
it is not known whether this causes liver folate and liver
SAM to rise a lot in folate sufficient individuals.
Liver cells are not static but are constantly chang-
ing dynamic systems because the cells must continue
to operate in the face of dramatically changing inputs
due to meals. It is not surprising that liver cells have
evolved many complicated and ingeneous mechanisms
for accomplishing the homeostasis of important reac-
tions like the methyltransferase reactions. The purpose
of our discussion of AS3MT is to illustrate that a
thorough understanding of how competing methyltrans-
ferases are regulated is necessary for designing successful
interventions.
Conclusions
There are more than 150 methyltransferase reactions in
which a methyl group is transferred from SAM to another
substrate. These reactions are important steps in a wide
variety of biological mechanisms such as the biosynthe-
sis of a large variety of useful compounds, methylating
the cytosines on DNA, and catabolizing neurotransmit-
ters. In any given cell typically only a certain subset of the
MTs are expressed depending on cell type, its function,
and the tasks that the cell is currently doing. The pri-
mary mechanism used by the cell for regulating the MTs
is to upregulate and downregulate the expression level of
the genes that code for the MTs. However, since all the
MTs use the same substrate, SAM, up and down regu-
lation of a particular MT will affect the flux in all MT
reactions, i.e. it is hard for the cell to regulate each of
MT fluxes independently. It is not surprising that cells
have developed a number of different mechanisms that
help them meet this challenge. In addition, cells must
cope with large changes in amino acid input (i.e. methio-
nine) that happen on a shorter time scale than gene
regulation.
In this paper, we have used a mathematical model to
investigate the mechanisms that liver cells use to manage
the non-independence of the MT fluxes.
(1) We have found that long-range allosteric interactions
in which substrates in one part of the network affect
enzyme activity in distant parts of the network play
an important role:
(1a) The long-range interactions ensure that when
oneMT is greatly upregulated or downregulated
the GNMT pathway changes a lot so that the
fluxes in the other MT pathways change only
modestly (Fig. 3). SAM changes much more in
the presence of MT up and down regulation
without the long-range interactions (Fig. 4).
(1b) The long-range interactions act to conserve
total mass in the methionine cycle. SAM
changes linearly and slowly as methionine
input changes (Fig. 5).
(1c) The long-range interactions stabilize total
methylation against folate deficiency (Fig. 6b).
(2) We have provided computational evidence that
GNMT that is bound to one 5mTHF molecule
retains substantial activity. This remains to be
confirmed experimentally.
(3) We explained why the small Km values of many MTs
for SAMmakes them independent of the fluxes
through other MT reactions.
(4) We explained why the small Ki value of SAH for
PEMT stabilizes PEMT flux.
And finally, we discussed why a full understanding of
the regulation ofMT fluxes is important for human health
interventions to ameliorate arsenic toxicity in Bangladesh.
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